US5744347A
(en)
*
|
1987-01-16 |
1998-04-28 |
Ohio University Edison Biotechnology Institute |
Yolk sac stem cells and their uses
|
US5763266A
(en)
*
|
1989-06-15 |
1998-06-09 |
The Regents Of The University Of Michigan |
Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
|
US5635386A
(en)
*
|
1989-06-15 |
1997-06-03 |
The Regents Of The University Of Michigan |
Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
|
US5399493A
(en)
*
|
1989-06-15 |
1995-03-21 |
The Regents Of The University Of Michigan |
Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
|
US5605822A
(en)
*
|
1989-06-15 |
1997-02-25 |
The Regents Of The University Of Michigan |
Methods, compositions and devices for growing human hematopoietic cells
|
US5061620A
(en)
*
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
US5635387A
(en)
*
|
1990-04-23 |
1997-06-03 |
Cellpro, Inc. |
Methods and device for culturing human hematopoietic cells and their precursors
|
US5840580A
(en)
*
|
1990-05-01 |
1998-11-24 |
Becton Dickinson And Company |
Phenotypic characterization of the hematopoietic stem cell
|
US5622853A
(en)
*
|
1990-05-01 |
1997-04-22 |
Becton Dickinson And Company |
T lymphocyte precursor
|
US6631842B1
(en)
*
|
2000-06-07 |
2003-10-14 |
Metrologic Instruments, Inc. |
Method of and system for producing images of objects using planar laser illumination beams and image detection arrays
|
US5541072A
(en)
*
|
1994-04-18 |
1996-07-30 |
Immunivest Corporation |
Method for magnetic separation featuring magnetic particles in a multi-phase system
|
US6010696A
(en)
*
|
1990-11-16 |
2000-01-04 |
Osiris Therapeutics, Inc. |
Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
|
US5340719A
(en)
*
|
1990-11-23 |
1994-08-23 |
Corporation Coulter |
Method and apparatus for optically screening microscopic cells
|
US5348859A
(en)
*
|
1990-11-23 |
1994-09-20 |
Coulter Corporation |
Method and apparatus for obtaining an absolute white blood cell subset count and white blood cell multipart differential
|
US5464753A
(en)
*
|
1991-03-08 |
1995-11-07 |
Univ Illinois |
Purification and manipulation of bone marrow and blood cells on the basis of P-glycoprotein expression
|
US5994088A
(en)
|
1991-03-08 |
1999-11-30 |
Board Of Trustees Of The University Of Illinois |
Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
|
US5849686A
(en)
*
|
1991-03-11 |
1998-12-15 |
Creative Biomolecules, Inc. |
Morphogen-induced liver regeneration
|
US5795470A
(en)
*
|
1991-03-25 |
1998-08-18 |
Immunivest Corporation |
Magnetic separation apparatus
|
US5367057A
(en)
*
|
1991-04-02 |
1994-11-22 |
The Trustees Of Princeton University |
Tyrosine kinase receptor flk-2 and fragments thereof
|
US5185438A
(en)
*
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
WO1992017505A1
(en)
*
|
1991-04-05 |
1992-10-15 |
Board Of Regents Of The University Of Washington |
Monoclonal antibodies to stem cell factor receptors
|
US5744361A
(en)
*
|
1991-04-09 |
1998-04-28 |
Indiana University |
Expansion of human hematopoietic progenitor cells in a liquid medium
|
US5409825A
(en)
*
|
1991-04-09 |
1995-04-25 |
Indiana University Foundation |
Expansion of human hematopoietic progenitor cells in a liquid medium
|
US6069005A
(en)
|
1991-08-07 |
2000-05-30 |
Albert Einstein College Of Medicine Of Yeshwa University |
Hapatoblasts and method of isolating same
|
AU667680B2
(en)
*
|
1991-08-07 |
1996-04-04 |
Albert Einstein College Of Medicine Of Yeshiva University |
Proliferation of hepatocyte precursors
|
NL9101680A
(nl)
*
|
1991-10-04 |
1993-05-03 |
Tno |
Werkwijze voor het genetisch modificeren van beenmergcellen van primaten, alsmede daarbij bruikbare cellen die recombinante retrovirale vectoren produceren.
|
CA2122140A1
(en)
*
|
1991-10-23 |
1993-04-29 |
Dale R. Peterson |
Method for freezing engrafting cells
|
ES2180539T3
(es)
*
|
1991-10-23 |
2003-02-16 |
Nexell Therapeutics Inc |
Metodos para expandir selectivamente celulas madre.
|
US6353150B1
(en)
*
|
1991-11-22 |
2002-03-05 |
Hsc Research And Development Limited Partnership |
Chimeric mammals with human hematopoietic cells
|
WO1993018136A1
(en)
*
|
1992-03-05 |
1993-09-16 |
Cytomed, Inc. |
Process for supporting hematopoietic progenitor cells
|
US5888499A
(en)
*
|
1992-03-23 |
1999-03-30 |
Nexell Therapeutics Inc. |
Method for increasing neutrophil populations using in vitro-derived human neutrophil precursor cells
|
SG47041A1
(en)
*
|
1992-03-23 |
1998-03-20 |
Bender James G |
In vitro-derived human neutrophil precursor cells
|
US5436151A
(en)
*
|
1992-04-03 |
1995-07-25 |
Regents Of The University Of Minnesota |
Method for culturing human hematopoietic stem cells in vitro
|
US5460964A
(en)
*
|
1992-04-03 |
1995-10-24 |
Regents Of The University Of Minnesota |
Method for culturing hematopoietic cells
|
IL106295A
(en)
*
|
1992-07-10 |
2001-03-19 |
Univ Pittsburgh |
Hematopoietic facilitaroy cells
|
PT652943E
(pt)
*
|
1992-07-10 |
2008-10-09 |
Univ Pittsburgh |
Células hematopoiéticas facilitadoras e seus usos
|
CA2140884A1
(en)
*
|
1992-07-27 |
1994-02-03 |
David J. Anderson |
Mammalian multipotent neural stem cells
|
US5589376A
(en)
*
|
1992-07-27 |
1996-12-31 |
California Institute Of Technology |
Mammalian neural crest stem cells
|
US5654183A
(en)
*
|
1992-07-27 |
1997-08-05 |
California Institute Of Technology |
Genetically engineered mammalian neural crest stem cells
|
US5672499A
(en)
*
|
1992-07-27 |
1997-09-30 |
California Institute Of Technology |
Immoralized neural crest stem cells and methods of making
|
US5849553A
(en)
*
|
1992-07-27 |
1998-12-15 |
California Institute Of Technology |
Mammalian multipotent neural stem cells
|
EP0652703A4
(de)
*
|
1992-07-28 |
1996-05-29 |
Steven Kessler |
Verfahren für die positive immunoselektion von stammzellen.
|
CA2080255A1
(en)
*
|
1992-07-31 |
1994-02-01 |
Connie J. Eaves |
Primitive hematopoietic stem cell preparations
|
PT662124E
(pt)
*
|
1992-09-03 |
2002-10-31 |
Univ California |
Separacao citometrica de fluxo de alta velocidade de celulas viaveis de mamifero
|
US5466572A
(en)
*
|
1992-09-03 |
1995-11-14 |
Systemix, Inc. |
High speed flow cytometric separation of viable cells
|
US5342776A
(en)
*
|
1992-09-04 |
1994-08-30 |
Bolnet Marie C N |
Avian hemopoietic progenitor cells
|
AU5143393A
(en)
*
|
1992-10-02 |
1994-04-26 |
Systemix, Inc. |
Method of enrichment for human hematopoietic stem cells using c-kit
|
US5766951A
(en)
*
|
1992-11-12 |
1998-06-16 |
Quality Biological, Inc. |
Serum-free medium supporting growth and proliferation of normal bone marrow cells
|
CA2148712C
(en)
*
|
1992-11-13 |
2012-01-17 |
Thalia Papayannopoulou |
Peripheralization of hematopoietic stem cells
|
WO1994011493A1
(en)
*
|
1992-11-16 |
1994-05-26 |
Applied Immune Sciences, Inc. |
Pluripotential quiescent stem cell population
|
US5409710A
(en)
*
|
1993-04-20 |
1995-04-25 |
Endocon, Inc. |
Foam cell drug delivery
|
CA2159330C
(en)
*
|
1993-05-03 |
2004-06-15 |
Laurence A. Lasky |
Inhibition of leukocyte adhesion
|
NZ314644A
(en)
|
1993-05-24 |
2000-11-24 |
Immunex Corp |
Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue
|
US5554512A
(en)
*
|
1993-05-24 |
1996-09-10 |
Immunex Corporation |
Ligands for flt3 receptors
|
WO1994027622A1
(en)
*
|
1993-05-24 |
1994-12-08 |
The Johns Hopkins University |
Surrogate tolerogenesis for the development of tolerance to xenografts
|
US5772994A
(en)
*
|
1993-05-28 |
1998-06-30 |
The University Of Pittsburgh |
Hematopoietic facilitatory cells and their uses
|
US6033906A
(en)
*
|
1993-07-26 |
2000-03-07 |
California Institute Of Technology |
Methods for differentiating neural stem cells to glial cells using neuregulins
|
JPH09502167A
(ja)
*
|
1993-07-29 |
1997-03-04 |
システミックス,インコーポレイテッド |
新規な幹細胞マーカー
|
EP0722331A4
(de)
*
|
1993-08-25 |
1997-10-01 |
Systemix Inc |
Verfahren zur herstellung einer hoch angreicherten population von hämatopoietischen stammzellen
|
EP0722489B1
(de)
*
|
1993-09-08 |
2002-04-03 |
Imclone Systems, Inc. |
Monoklonale antikörper, die flk-2-rezeptoren erkennen, und die isolierung primitiver hämatopoietischer stammzellpopulationen
|
WO1995008105A1
(en)
*
|
1993-09-17 |
1995-03-23 |
Systemix, Inc. |
Method for obtaining a cell population enriched in stem cells and compositions derived therefrom
|
US5409813A
(en)
*
|
1993-09-30 |
1995-04-25 |
Systemix, Inc. |
Method for mammalian cell separation from a mixture of cell populations
|
US5599703A
(en)
*
|
1993-10-28 |
1997-02-04 |
The United States Of America As Represented By The Secretary Of The Navy |
In vitro amplification/expansion of CD34+ stem and progenitor cells
|
US6190655B1
(en)
|
1993-12-03 |
2001-02-20 |
Immunex Corporation |
Methods of using Flt-3 ligand for exogenous gene transfer
|
ATE276277T1
(de)
*
|
1994-01-05 |
2004-10-15 |
Univ Pittsburgh |
Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden
|
US6001654A
(en)
*
|
1994-01-28 |
1999-12-14 |
California Institute Of Technology |
Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
|
US6448077B1
(en)
*
|
1994-02-10 |
2002-09-10 |
Imclone Systems, Inc. |
Chimeric and humanized monoclonal antibodies specific to VEGF receptors
|
US20030108545A1
(en)
*
|
1994-02-10 |
2003-06-12 |
Patricia Rockwell |
Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
|
US7294331B2
(en)
*
|
1994-03-07 |
2007-11-13 |
Immunex Corporation |
Methods of using flt3-ligand in hematopoietic cell transplantation
|
US6242417B1
(en)
|
1994-03-08 |
2001-06-05 |
Somatogen, Inc. |
Stabilized compositions containing hemoglobin
|
US5631219A
(en)
*
|
1994-03-08 |
1997-05-20 |
Somatogen, Inc. |
Method of stimulating hematopoiesis with hemoglobin
|
US5972627A
(en)
*
|
1994-06-15 |
1999-10-26 |
Systemix, Inc. |
Method of purifying a population of cells enriched for dendritic and/or lymphoid progenitors and populations of cells obtained thereby
|
JP3957746B2
(ja)
*
|
1994-06-15 |
2007-08-15 |
ノバルティス アクチエンゲゼルシャフト |
骨髄始原細胞および/またはリンパ系始原細胞について富化される細胞集団、ならびに製造方法および使用方法
|
US5985660A
(en)
*
|
1994-06-15 |
1999-11-16 |
Systemix, Inc. |
Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
|
US5972703A
(en)
*
|
1994-08-12 |
1999-10-26 |
The Regents Of The University Of Michigan |
Bone precursor cells: compositions and methods
|
US5474687A
(en)
*
|
1994-08-31 |
1995-12-12 |
Activated Cell Therapy, Inc. |
Methods for enriching CD34+ human hematopoietic progenitor cells
|
US5827742A
(en)
*
|
1994-09-01 |
1998-10-27 |
Beth Israel Deaconess Medical Center, Inc. |
Method of selecting pluripotent hematopioetic progenitor cells
|
US6140119A
(en)
*
|
1994-09-16 |
2000-10-31 |
Michigan State University |
Expression of estrogen receptors in type I and type II human breast epithelial cells
|
US5650317A
(en)
*
|
1994-09-16 |
1997-07-22 |
Michigan State University |
Human breast epithelial cell type with stem cell and luminal epithelial cell characteristics
|
US5686577A
(en)
*
|
1994-10-17 |
1997-11-11 |
Cornell Research Foundation, Inc. |
T cell factors influencing B cell development
|
US5677136A
(en)
*
|
1994-11-14 |
1997-10-14 |
Systemix, Inc. |
Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
|
US5665557A
(en)
*
|
1994-11-14 |
1997-09-09 |
Systemix, Inc. |
Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
|
WO1996015227A1
(en)
*
|
1994-11-14 |
1996-05-23 |
Novartis Ag |
Methods of inducing cell death of primitive hematopoietic cells and compositions for induction thereof
|
US5610056A
(en)
*
|
1994-11-16 |
1997-03-11 |
Amgen Inc. |
Use of stem cell factor interleukin-6 and soluble interleukin-6 receptor to induce the development of hematopoietic stem cells
|
US5874301A
(en)
*
|
1994-11-21 |
1999-02-23 |
National Jewish Center For Immunology And Respiratory Medicine |
Embryonic cell populations and methods to isolate such populations
|
US5665350A
(en)
*
|
1994-11-23 |
1997-09-09 |
University Of Massachusetts Medical Center |
Cell cycle dependent transplantation and ex vivo gene therapy
|
CA2206449A1
(en)
*
|
1994-12-01 |
1996-06-06 |
Beth Israel Deaconess Medical Center, Inc. |
In vitro t-lymphopoiesis system
|
US5843780A
(en)
*
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
GB9502022D0
(en)
*
|
1995-02-02 |
1995-03-22 |
Abuljadayel Ilham M S |
A method for preparing lymphohaematopoietic progenitor cells
|
US9068164B1
(en)
*
|
1995-02-02 |
2015-06-30 |
Tristem Trading (Cyprus) Limited |
Method of preparing an undifferentiated cell
|
US5830755A
(en)
*
|
1995-03-27 |
1998-11-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
T-cell receptors and their use in therapeutic and diagnostic methods
|
US5876956A
(en)
*
|
1995-05-15 |
1999-03-02 |
Johns Hopkins University School Of Medicine |
Methods for identification or purification of cells containing an enzymatic intracellular marker
|
US5925567A
(en)
*
|
1995-05-19 |
1999-07-20 |
T. Breeders, Inc. |
Selective expansion of target cell populations
|
US5674750A
(en)
*
|
1995-05-19 |
1997-10-07 |
T. Breeders |
Continuous selective clonogenic expansion of relatively undifferentiated cells
|
US5728581A
(en)
*
|
1995-06-07 |
1998-03-17 |
Systemix, Inc. |
Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
|
US5861313A
(en)
*
|
1995-06-07 |
1999-01-19 |
Ontogeny, Inc. |
Method of isolating bile duct progenitor cells
|
US6015554A
(en)
*
|
1995-06-07 |
2000-01-18 |
Systemix, Inc. |
Method of reconstituting human lymphoid and dendritic cells
|
WO1996040875A1
(en)
*
|
1995-06-07 |
1996-12-19 |
Novartis Ag |
Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein
|
US20020182730A1
(en)
*
|
1995-07-26 |
2002-12-05 |
Micheal L. Gruenberg |
Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
|
US7361330B2
(en)
*
|
1995-10-04 |
2008-04-22 |
Immunex Corporation |
Methods of using flt3-ligand in the treatment of fibrosarcoma
|
US7150992B1
(en)
|
1995-10-04 |
2006-12-19 |
Innunex Corporation |
Methods of preparing dendritic cells with flt3-ligand and antigen
|
US20020034517A1
(en)
*
|
1995-10-04 |
2002-03-21 |
Kenneth Brasel |
Dendritic cell stimulatory factor
|
US6060052A
(en)
*
|
1995-10-30 |
2000-05-09 |
Systemix, Inc. |
Methods for use of Mpl ligands with primitive human hematopoietic stem cells
|
US5910434A
(en)
*
|
1995-12-15 |
1999-06-08 |
Systemix, Inc. |
Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant
|
WO1997022708A1
(en)
*
|
1995-12-19 |
1997-06-26 |
Systemix, Inc. |
Primate cluster-forming embryonic hematopoietic stem cells
|
EP0877795A4
(de)
*
|
1996-01-16 |
2003-03-05 |
Depuy Orthopaedics Inc |
Isolierung von vorläuferzellen aus hematopoietischen und nicht hematopoietischen gewebe und deren verwendung
|
JP2000507812A
(ja)
|
1996-03-12 |
2000-06-27 |
ライフ テクノロジーズ,インコーポレイテッド |
造血細胞培養栄養補充成分
|
US6455678B1
(en)
*
|
1996-04-26 |
2002-09-24 |
Amcell Corporation |
Human hematopoietic stem and progenitor cell antigen
|
US5843633A
(en)
*
|
1996-04-26 |
1998-12-01 |
Amcell Corporation |
Characterization of a human hematopoietic progenitor cell antigen
|
US5928638A
(en)
*
|
1996-06-17 |
1999-07-27 |
Systemix, Inc. |
Methods for gene transfer
|
CA2260014A1
(en)
*
|
1996-07-10 |
1998-01-15 |
Meiji Milk Products Co., Ltd. |
Novel use of mk family as hematopoietic factor
|
NZ334016A
(en)
*
|
1996-08-19 |
2000-08-25 |
Univ Massachusetts |
Embryonic stem cell lines produced by cross species nuclear transplantation
|
US7696404B2
(en)
*
|
1996-08-19 |
2010-04-13 |
Advanced Cell Technology, Inc. |
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
|
US5945337A
(en)
|
1996-10-18 |
1999-08-31 |
Quality Biological, Inc. |
Method for culturing CD34+ cells in a serum-free medium
|
AU7180398A
(en)
|
1996-11-13 |
1998-06-03 |
Morphogenesis, Inc. |
Antibody MG1 recognizing a small subset of human hematopoietic cells
|
WO1998025634A1
(en)
*
|
1996-12-10 |
1998-06-18 |
Hadasit Medical Research Services & Development Company Ltd. |
Serum-derived factor inducing cell differentiation and medical uses thereof
|
JP2001524942A
(ja)
*
|
1997-02-24 |
2001-12-04 |
ティーエム テクノロジーズ,インク. |
アンチセンス・オリゴヌクレオチド薬物
|
US6331406B1
(en)
|
1997-03-31 |
2001-12-18 |
The John Hopkins University School Of Medicine |
Human enbryonic germ cell and methods of use
|
US6090622A
(en)
*
|
1997-03-31 |
2000-07-18 |
The Johns Hopkins School Of Medicine |
Human embryonic pluripotent germ cells
|
US5948426A
(en)
*
|
1997-05-03 |
1999-09-07 |
Jefferies; Steven R. |
Method and article to induce hematopoietic expansion
|
AU9472998A
(en)
*
|
1997-09-04 |
1999-03-22 |
Science Research Laboratory, Inc. |
Cell separation using electric fields
|
US6440734B1
(en)
*
|
1998-09-25 |
2002-08-27 |
Cytomatrix, Llc |
Methods and devices for the long-term culture of hematopoietic progenitor cells
|
US6093531A
(en)
*
|
1997-09-29 |
2000-07-25 |
Neurospheres Holdings Ltd. |
Generation of hematopoietic cells from multipotent neural stem cells
|
US5955257A
(en)
|
1997-10-21 |
1999-09-21 |
Regents Of The University Of Minnesota |
Infusible grade short-term cell storage medium for mononuclear cells
|
US7294755B1
(en)
|
1997-11-14 |
2007-11-13 |
Cedars-Sinai Medical Center |
Genetic modification of male germ cells for generation of transgenic species and genetic therapies
|
US6734338B1
(en)
|
1997-11-14 |
2004-05-11 |
Cedars-Sinai Medical Center |
Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies
|
AU761758B2
(en)
*
|
1997-11-14 |
2003-06-12 |
Cedars-Sinai Medical Center |
Transfection and transfer of male germ cells for generation of transgenic species
|
US6361642B1
(en)
|
1997-12-02 |
2002-03-26 |
Baxter International Inc. |
Heat and pressure-formed flexible containers
|
AU753975B2
(en)
*
|
1997-12-04 |
2002-10-31 |
Duke University |
Methods of isolating and using CD7+CD34-Lin-hematopoietic cells
|
US6059968A
(en)
*
|
1998-01-20 |
2000-05-09 |
Baxter International Inc. |
Systems for processing and storing placenta/umbilical cord blood
|
JP2002500879A
(ja)
*
|
1998-01-23 |
2002-01-15 |
イムクローン システムズ インコーポレーテッド |
幹細胞の精製ポピュレーション
|
US20020034819A1
(en)
*
|
1998-02-23 |
2002-03-21 |
Alan K. Smith |
Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
|
AU4216599A
(en)
|
1998-05-29 |
1999-12-13 |
Case Western Reserve University |
Hematopoietic progenitor cell gene transduction
|
US6451558B1
(en)
*
|
1998-08-03 |
2002-09-17 |
Novartis Ag |
Genes in the control of hematopoiesis
|
JP2002523039A
(ja)
*
|
1998-08-24 |
2002-07-30 |
ティー.ブリーダーズ,インコーポレイテッド |
非胎児血管芽細胞を含む細胞集団、およびその生産方法
|
WO2000014203A1
(fr)
*
|
1998-09-02 |
2000-03-16 |
Chugai Seiyaku Kabushiki Kaisha |
Procede de preparation d'une fraction de cellule contenant des cellules souches hematopoietiques
|
US8297377B2
(en)
*
|
1998-11-20 |
2012-10-30 |
Vitruvian Exploration, Llc |
Method and system for accessing subterranean deposits from the surface and tools therefor
|
DE69942185D1
(de)
*
|
1998-12-07 |
2010-05-06 |
Univ Duke |
BODIPY Aminoacetaldehyd Diethyl Acetal
|
WO2000043499A2
(en)
*
|
1999-01-25 |
2000-07-27 |
Seattle Biomedical Research Institute |
ANTI-TRANSFORMING GROWTH FACTOR BETA (TGF-β) TREATED STEM CELL COMPOSITION AND METHOD
|
ATE284220T1
(de)
*
|
1999-02-03 |
2004-12-15 |
Idm Immuno Designed Molecules |
Makrophagenhaltige zusammensetzung mit antiinfektiösen und hematopoietischen eigenschaften sowie deren herstellungsmethode
|
US6153113A
(en)
|
1999-02-22 |
2000-11-28 |
Cobe Laboratories, Inc. |
Method for using ligands in particle separation
|
US6238922B1
(en)
|
1999-02-26 |
2001-05-29 |
Stemcells, Inc. |
Use of collagenase in the preparation of neural stem cell cultures
|
US20040265285A1
(en)
*
|
1999-04-15 |
2004-12-30 |
Monash University |
Normalization of defective T cell responsiveness through manipulation of thymic regeneration
|
AUPR074500A0
(en)
*
|
2000-10-13 |
2000-11-09 |
Monash University |
Treatment of t cell disorders
|
US20040258672A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Graft acceptance through manipulation of thymic regeneration
|
US20040259803A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Disease prevention by reactivation of the thymus
|
US20070274946A1
(en)
*
|
1999-04-15 |
2007-11-29 |
Norwood Immunoloty, Ltd. |
Tolerance to Graft Prior to Thymic Reactivation
|
US20040241842A1
(en)
*
|
1999-04-15 |
2004-12-02 |
Monash University |
Stimulation of thymus for vaccination development
|
US20050020524A1
(en)
*
|
1999-04-15 |
2005-01-27 |
Monash University |
Hematopoietic stem cell gene therapy
|
US7759113B2
(en)
*
|
1999-04-30 |
2010-07-20 |
The General Hospital Corporation |
Fabrication of tissue lamina using microfabricated two-dimensional molds
|
US7371400B2
(en)
|
2001-01-02 |
2008-05-13 |
The General Hospital Corporation |
Multilayer device for tissue engineering
|
CA2370781A1
(en)
*
|
1999-04-30 |
2000-11-09 |
Joseph P. Vacanti |
Fabrication of vascularized tissue using microfabricated two-dimensional molds
|
JP2003530899A
(ja)
*
|
1999-06-23 |
2003-10-21 |
オレゴン ヘルス アンド サイエンス ユニバーシティー |
造血を増強する方法
|
US6821513B1
(en)
|
1999-06-23 |
2004-11-23 |
Oregon Health & Science University |
Method for enhancing hematopoiesis
|
US8252280B1
(en)
|
1999-08-05 |
2012-08-28 |
Regents Of The University Of Minnesota |
MAPC generation of muscle
|
US7015037B1
(en)
|
1999-08-05 |
2006-03-21 |
Regents Of The University Of Minnesota |
Multiponent adult stem cells and methods for isolation
|
US10638734B2
(en)
|
2004-01-05 |
2020-05-05 |
Abt Holding Company |
Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
|
WO2001011011A2
(en)
|
1999-08-05 |
2001-02-15 |
Mcl Llc |
Multipotent adult stem cells and methods for isolation
|
US7994278B1
(en)
|
1999-08-06 |
2011-08-09 |
Nobel Biosciences Llc |
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
|
US6749850B1
(en)
|
1999-08-18 |
2004-06-15 |
The General Hospital Corporation |
Methods, compositions and kits for promoting recovery from damage to the central nervous system
|
WO2001023528A1
(en)
*
|
1999-09-27 |
2001-04-05 |
University Of Florida Research Foundation |
Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
|
CN1423523A
(zh)
*
|
1999-11-17 |
2003-06-11 |
罗切斯特大学 |
来自人体内的免疫***
|
US6790614B1
(en)
|
1999-11-19 |
2004-09-14 |
Novartis Ag |
Selectable cell surface marker genes
|
US7112576B1
(en)
|
1999-12-10 |
2006-09-26 |
Regents Of The University Of Minnesota |
Compositions and methods for cryopreservation of peripheral blood lymphocytes
|
JP2004500066A
(ja)
*
|
1999-12-20 |
2004-01-08 |
ユニバシティ オブ マサチューセッツ、ア パブリック インスチチユーション オブ ハイアー エデュケイション オブ ザ コモンウエルス オブ マサチューセッツ、アズ リプリゼンテッド バイ イッツ ア |
異種間核移植により生成する胚あるいは幹様細胞
|
WO2001068148A1
(en)
*
|
2000-03-15 |
2001-09-20 |
Children's Medical Center Corporation |
Systemic gene delivery vehicles for the treatment of tumors
|
JP4966470B2
(ja)
*
|
2000-04-14 |
2012-07-04 |
ダニスコ・ユーエス・インコーポレーテッド |
選択性標的化方法
|
US7129326B2
(en)
*
|
2000-04-14 |
2006-10-31 |
Genencor International, Inc. |
Methods for selective targeting
|
US7776021B2
(en)
*
|
2000-04-28 |
2010-08-17 |
The Charles Stark Draper Laboratory |
Micromachined bilayer unit for filtration of small molecules
|
AR028039A1
(es)
|
2000-05-03 |
2003-04-23 |
Oncolytics Biotech Inc |
Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
|
US8491884B2
(en)
|
2000-05-03 |
2013-07-23 |
Oncolytics Biotech Inc. |
Virus clearance of neoplastic cells from mixed cellular compositions
|
AR028040A1
(es)
*
|
2000-05-03 |
2003-04-23 |
Oncolytics Biotech Inc |
Remocion de virus de celulas neoplasticas a partir de composiciones celulares mixtas
|
US6828145B2
(en)
*
|
2000-05-10 |
2004-12-07 |
Cedars-Sinai Medical Center |
Method for the isolation of stem cells by immuno-labeling with HLA/MHC gene product marker
|
CA2412436C
(en)
*
|
2000-06-05 |
2013-05-21 |
The Trustees Of Columbia University In The City Of New York |
Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
|
FR2810045B1
(fr)
*
|
2000-06-07 |
2004-09-03 |
Assist Publ Hopitaux De Paris |
Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
|
US6632620B1
(en)
*
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
US8044259B2
(en)
*
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
EP1978090A1
(de)
|
2000-08-09 |
2008-10-08 |
ES Cell International Pte Ltd. |
Pankreatische Vorläuferzellen
|
US20060088512A1
(en)
*
|
2001-10-15 |
2006-04-27 |
Monash University |
Treatment of T cell disorders
|
US20020151050A1
(en)
*
|
2000-10-30 |
2002-10-17 |
Vacanti Charles A. |
Isolation of spore-like cells from tissues exposed to extreme conditions
|
AU3929402A
(en)
*
|
2000-11-22 |
2002-06-11 |
Geron Corp |
Tolerizing allografts of pluripotent stem cells
|
US6576464B2
(en)
*
|
2000-11-27 |
2003-06-10 |
Geron Corporation |
Methods for providing differentiated stem cells
|
US6921665B2
(en)
*
|
2000-11-27 |
2005-07-26 |
Roslin Institute (Edinburgh) |
Selective antibody targeting of undifferentiated stem cells
|
WO2002044345A1
(en)
*
|
2000-12-01 |
2002-06-06 |
The General Hospital Corporation |
Methods and products for manipulating hematopoietic stem cells
|
EP3299452A1
(de)
|
2000-12-06 |
2018-03-28 |
Anthrogenesis Corporation |
Verfahren zum sammeln plazentärer stammzellen
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
US20080152629A1
(en)
*
|
2000-12-06 |
2008-06-26 |
James Edinger |
Placental stem cell populations
|
US20030147874A1
(en)
*
|
2000-12-14 |
2003-08-07 |
Volker Schellenberger |
Targeted enzyme prodrug therapy
|
US20030049689A1
(en)
*
|
2000-12-14 |
2003-03-13 |
Cynthia Edwards |
Multifunctional polypeptides
|
US20080248544A1
(en)
*
|
2000-12-14 |
2008-10-09 |
Murray Christopher J |
Methods And Compositions For Grafting Functional Loops Into A Protein
|
US20030068792A1
(en)
*
|
2000-12-14 |
2003-04-10 |
Yiyou Chen |
Targeted enzymes
|
EP1379139A4
(de)
*
|
2000-12-19 |
2004-12-01 |
Insight Strategy & Marketing |
Verwendung ecm abbauender enzyme zur verbesserung der zelltransplantation
|
IL157332A0
(en)
*
|
2001-02-14 |
2004-02-19 |
|
Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
|
CA2438153C
(en)
|
2001-02-14 |
2015-06-02 |
Anthrogenesis Corporation |
Post-partum mammalian placenta, its use and placental stem cells therefrom
|
US7723111B2
(en)
*
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
FR2821947B1
(fr)
*
|
2001-03-12 |
2003-05-16 |
Canon Kk |
Procede et dispositif de validation de parametres definissant une image
|
CA2442177A1
(en)
*
|
2001-03-29 |
2002-10-10 |
Ixion Biotechnology, Inc. |
Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
|
US20030095952A1
(en)
*
|
2001-06-13 |
2003-05-22 |
Krause Diane S. |
Multi-organ engraftment with a single bone marrow-derived stem cell
|
JP4493882B2
(ja)
*
|
2001-06-19 |
2010-06-30 |
株式会社カネカ |
抗原およびこの抗原を識別するモノクローナル抗体
|
WO2003000183A2
(en)
*
|
2001-06-20 |
2003-01-03 |
Imclone Systems Incorporated |
Method of treating atherosclerosis and other inflammatory diseases
|
CA2454251A1
(en)
*
|
2001-08-10 |
2003-02-20 |
Imclone Systems Incorporated |
Isolation and mobilization of stem cells expressing vegfr-1
|
US20030049836A1
(en)
*
|
2001-08-15 |
2003-03-13 |
Phi-Wilson Janette T. |
Cell separation system
|
DE10144326B4
(de)
*
|
2001-09-10 |
2005-09-22 |
Siemens Ag |
Verfahren und System zur Überwachung eines Reifenluftdrucks
|
US20030134415A1
(en)
*
|
2001-09-19 |
2003-07-17 |
Gruenberg Micheal L. |
Th1 cell adoptive immunotherapy
|
US20030134341A1
(en)
*
|
2001-09-19 |
2003-07-17 |
Medcell Biologics, Llc. |
Th1 cell adoptive immunotherapy
|
US9969980B2
(en)
*
|
2001-09-21 |
2018-05-15 |
Garnet Biotherapeutics |
Cell populations which co-express CD49c and CD90
|
CA2461290C
(en)
|
2001-09-24 |
2014-11-25 |
Sangamo Biosciences, Inc. |
Modulation of stem cells using zinc finger proteins
|
US20030119080A1
(en)
*
|
2001-10-15 |
2003-06-26 |
Mangano Joseph A. |
Strategies for the identification and isolation of cancer stem cells and non-cancerous stem cells
|
US7129034B2
(en)
*
|
2001-10-25 |
2006-10-31 |
Cedars-Sinai Medical Center |
Differentiation of whole bone marrow
|
US6759244B2
(en)
|
2001-11-08 |
2004-07-06 |
Art Institute Of New York And New Jersey, Inc. |
Composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos
|
US7799324B2
(en)
*
|
2001-12-07 |
2010-09-21 |
Geron Corporation |
Using undifferentiated embryonic stem cells to control the immune system
|
US20040224403A1
(en)
*
|
2001-12-07 |
2004-11-11 |
Robarts Research Institute |
Reconstituting hematopoietic cell function using human embryonic stem cells
|
CA2469204A1
(en)
*
|
2001-12-07 |
2003-06-19 |
Regents Of The University Of Michigan |
Prospective identification and characterization of breast cancer stem cells
|
GB2412379B
(en)
|
2001-12-07 |
2006-03-29 |
Geron Corp |
Hematopoietic cells from human embryonic stem cells
|
US7190781B2
(en)
*
|
2002-01-04 |
2007-03-13 |
Telefonaktiebolaget Lm Ericsson (Publ) |
Message transfer part point code mapping method and node
|
DK1916001T3
(da)
*
|
2002-03-04 |
2011-07-18 |
Imclone Llc |
KDR-specifikke humane antistoffer og anvendelser deraf
|
US20030175272A1
(en)
*
|
2002-03-07 |
2003-09-18 |
Medcell Biologics, Inc. |
Re-activated T-cells for adoptive immunotherapy
|
US20030199464A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
US20030215935A1
(en)
*
|
2002-05-14 |
2003-11-20 |
Coon David James |
Apparatus and method for isolating living cells from an encapsulated organ tissue sample
|
PT1458853E
(pt)
*
|
2002-05-16 |
2010-02-23 |
Absorber Ab |
Processos de prova directa de compatibilidade específicos para dadores
|
US6943021B2
(en)
*
|
2002-06-07 |
2005-09-13 |
Mattek Corporation |
Three dimensional vaginal tissue model containing immune cells
|
DE60326839D1
(de)
|
2002-06-12 |
2009-05-07 |
Genencor Int |
Verfahren zur verbesserung einer bindungseigenschaft eines moleküls
|
US20110158966A1
(en)
*
|
2002-07-23 |
2011-06-30 |
Judith Seligman |
Stem cells characterized by expression of germline specific genes
|
CA2493768A1
(en)
*
|
2002-07-23 |
2004-01-29 |
Nanodiagnostics, Inc. |
Embryonic stem cell markers and uses thereof
|
US7635477B2
(en)
|
2002-07-25 |
2009-12-22 |
The General Hospital Corporation |
Parathyroid hormone receptor activation and stem and progenitor cell expansion
|
CA2492295C
(en)
*
|
2002-07-25 |
2014-01-28 |
The General Hospital Corporation |
Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
|
US20040028661A1
(en)
*
|
2002-08-07 |
2004-02-12 |
Bartelmez Stephen H. |
Expansion of cells using thrombopoietin and anti-transforming growth factor-beta
|
EP1527162A1
(de)
*
|
2002-08-09 |
2005-05-04 |
Dr. H. Zech GmbH |
Verfahren zur erzeugung von zellinien sowie organen mithilfe differenzierfähiger zellen
|
US20050271639A1
(en)
|
2002-08-22 |
2005-12-08 |
Penn Marc S |
Genetically engineered cells for therapeutic applications
|
US20040044300A1
(en)
*
|
2002-09-03 |
2004-03-04 |
Donnie Rudd |
Method of replenishing cells damaged by treatment for cancer
|
US20040077985A1
(en)
*
|
2002-09-03 |
2004-04-22 |
Donnie Rudd |
Method of replenishing cells damaged by treatment for cancer
|
US9969977B2
(en)
|
2002-09-20 |
2018-05-15 |
Garnet Biotherapeutics |
Cell populations which co-express CD49c and CD90
|
JP4939055B2
(ja)
|
2002-11-13 |
2012-05-23 |
トマス ジェファソン ユニバーシティ |
癌の診断および治療のための組成物および方法
|
AU2003295444A1
(en)
*
|
2002-11-15 |
2004-06-15 |
The Board Of Trustees Of The University Of Illinois |
Methods for in vitro expansion of hematopoietic stem cells
|
WO2004047770A2
(en)
*
|
2002-11-26 |
2004-06-10 |
Anthrogenesis Corporation |
Cytotherapeutics, cytotherapeutic units and methods for treatments using them
|
US20040110286A1
(en)
*
|
2002-12-06 |
2004-06-10 |
The John P. Robarts Research Institute |
Method for making hematopoietic cells
|
WO2004065616A2
(en)
|
2003-01-16 |
2004-08-05 |
The General Hospital Corporation |
Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
|
KR20050105467A
(ko)
*
|
2003-02-13 |
2005-11-04 |
안트로제네시스 코포레이션 |
질병, 장애 또는 증상을 보유하는 개체의 치료에 있어서제대혈의 용도
|
US20070020242A1
(en)
*
|
2003-03-27 |
2007-01-25 |
Ixion Biotechnology, Inc. |
Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
|
EP1636351A4
(de)
|
2003-05-21 |
2007-04-04 |
Gen Hospital Corp |
Mikrofabrizierte zusammensetzungen und verfahren zur konstruktion von geweben mit mehreren zellarten
|
CA2528669A1
(en)
*
|
2003-06-09 |
2005-01-20 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
EP1702062A2
(de)
*
|
2003-06-11 |
2006-09-20 |
Jan Remmereit |
Kern-umprogrammierung von zellen für die therapeutische verwendung
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
US8153410B2
(en)
*
|
2003-07-07 |
2012-04-10 |
Fox Chase Cancer Center |
Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
|
US20060162014A1
(en)
|
2003-07-07 |
2006-07-20 |
Jaffe Eileen K |
Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
EP2927318B1
(de)
|
2003-08-08 |
2020-05-20 |
Sangamo Therapeutics, Inc. |
Verfahren und Zusammensetzungen für gezielte Spaltung und Rekombination
|
US20050042595A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Martin Haas |
Banking of multipotent amniotic fetal stem cells
|
GB0321337D0
(en)
*
|
2003-09-11 |
2003-10-15 |
Massone Mobile Advertising Sys |
Method and system for distributing advertisements
|
WO2005027841A2
(en)
*
|
2003-09-16 |
2005-03-31 |
University Of North Carolina At Chapel Hill |
Cells, compositions and methods for repressing b cell autoantibody secretion and for treating autoimmune disease
|
US7510877B2
(en)
*
|
2003-09-26 |
2009-03-31 |
The Regents Of The University Of Michigan |
Hematopoietic stem cell identification and isolation
|
EP1685236A4
(de)
*
|
2003-09-29 |
2008-01-23 |
Univ California |
Verfahren zur änderung der adhäsion, differenzierung und migration hämatopoetischer vorläuferzellen
|
AU2004291559B2
(en)
*
|
2003-11-19 |
2008-10-16 |
Australian Stem Cell Centre Limited |
Methods for producing blood products from pluripotent cells in cell culture
|
CN1913896B
(zh)
*
|
2003-12-02 |
2010-12-01 |
细胞基因公司 |
用于治疗和控制血红蛋白病和贫血病的方法和组合物
|
US20080279812A1
(en)
*
|
2003-12-05 |
2008-11-13 |
Norwood Immunology, Ltd. |
Disease Prevention and Vaccination Prior to Thymic Reactivation
|
AU2005209169B2
(en)
|
2004-01-16 |
2010-12-16 |
Carnegie Mellon University |
Cellular labeling for nuclear magnetic resonance techniques
|
US20050232927A1
(en)
*
|
2004-02-03 |
2005-10-20 |
The Regents Of The University Of Michigan |
Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
|
AU2004316477B2
(en)
|
2004-02-11 |
2010-10-07 |
Aldagen, Inc. |
Stem cell populations and methods of use
|
US20050201990A1
(en)
*
|
2004-03-09 |
2005-09-15 |
Suchitra Sumitran-Holgersson |
Endothelial progenitor cells and methods of use thereof
|
EP1730161B1
(de)
*
|
2004-03-25 |
2010-09-08 |
California Institute Of Technology |
Hybridisierungskettenreaktion
|
US7622108B2
(en)
*
|
2004-04-23 |
2009-11-24 |
Bioe, Inc. |
Multi-lineage progenitor cells
|
US7670596B2
(en)
*
|
2004-04-23 |
2010-03-02 |
Bioe, Inc. |
Multi-lineage progenitor cells
|
US20050265980A1
(en)
|
2004-05-14 |
2005-12-01 |
Becton, Dickinson And Company |
Cell culture environments for the serum-free expansion of mesenchymal stem cells
|
US20080233100A1
(en)
*
|
2004-06-30 |
2008-09-25 |
Yiyou Chen |
Targeted enzymes
|
JP2008505650A
(ja)
*
|
2004-07-12 |
2008-02-28 |
ソリン・グループ・イタリア・ソシエタ・ア・レスポンサビリタ・リミタータ |
ヒト細胞を増殖させるための装置及び方法
|
EP1799844B1
(de)
*
|
2004-09-10 |
2009-12-23 |
Genencor International, Inc. |
Verfahren zur erkennung von zielen
|
WO2006044650A2
(en)
*
|
2004-10-15 |
2006-04-27 |
Genencor International, Inc. |
Competitive differential screening
|
CN101048426A
(zh)
*
|
2004-10-22 |
2007-10-03 |
金克克国际有限公司 |
分离人抗体
|
CN105168250B
(zh)
|
2004-10-25 |
2019-02-05 |
塞勒兰特治疗公司 |
增殖骨髓细胞群体的方法及其应用
|
WO2006052991A2
(en)
|
2004-11-11 |
2006-05-18 |
The General Hosptial Corporation |
Parathyroid hormone receptor activation and stem and progenitor cell expansion
|
EP2377555A3
(de)
*
|
2004-11-18 |
2011-11-23 |
Imclone LLC |
Antikörper gegen den vaskulären endothelialen Wachstumsfaktorrezeptor-1
|
US20080044400A1
(en)
*
|
2004-12-09 |
2008-02-21 |
Volker Schellenberger |
Targeted enzyme prodrug therapy
|
GB0503918D0
(en)
*
|
2005-02-25 |
2005-04-06 |
Erasmus University |
Cell
|
US7727721B2
(en)
*
|
2005-03-08 |
2010-06-01 |
California Institute Of Technology |
Hybridization chain reaction amplification for in situ imaging
|
US20060252073A1
(en)
*
|
2005-04-18 |
2006-11-09 |
Regents Of The University Of Michigan |
Compositions and methods for the treatment of cancer
|
US20060269527A1
(en)
*
|
2005-05-26 |
2006-11-30 |
Australian Stem Cell Centre Limited |
Isolation of cells from bone
|
WO2006138275A2
(en)
*
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
US20070099209A1
(en)
*
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
JP2009502170A
(ja)
|
2005-07-26 |
2009-01-29 |
サンガモ バイオサイエンシズ インコーポレイテッド |
外来核酸配列の標的化された組込み及び発現
|
WO2007016566A2
(en)
*
|
2005-08-01 |
2007-02-08 |
Nupotential, Llc |
Production of reprogrammed cells with restored potential
|
EP1924606A4
(de)
|
2005-08-25 |
2010-01-13 |
Repair Technologies Inc |
Vorrichtungen, zusammensetzungen und verfahren zum schutz und zur reparatur von zellen und gewebe
|
CN103028120B
(zh)
|
2005-09-12 |
2015-08-12 |
俄亥俄州立大学研究基金会 |
用于诊断或治疗bcl2相关癌症的组合物和方法
|
US7960357B2
(en)
|
2005-10-07 |
2011-06-14 |
California Institute Of Technology |
PKR activation via hybridization chain reaction
|
US7462485B2
(en)
*
|
2005-10-07 |
2008-12-09 |
Glaser Lawrence F |
Modified erythrocytes and uses thereof
|
MX343814B
(es)
|
2005-10-13 |
2016-11-24 |
Anthrogenesis Corp |
Inmunomodulación usando celulas madre de la placenta.
|
CN102827287B
(zh)
|
2005-10-31 |
2015-08-12 |
昂考梅德药品有限公司 |
用于诊断和治疗癌症的组合物和方法
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
AU2006308847C1
(en)
|
2005-10-31 |
2012-05-10 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for treating and diagnosing cancer
|
PL2441461T3
(pl)
*
|
2005-11-07 |
2014-11-28 |
Pecora & Co Llc |
Kompozycje i sposoby naprawy uszkodzenia naczyniowego
|
US8637005B2
(en)
|
2005-11-07 |
2014-01-28 |
Amorcyte, Inc. |
Compositions and methods of vascular injury repair
|
US20110076255A1
(en)
|
2005-11-07 |
2011-03-31 |
Pecora Andrew L |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
US9155762B2
(en)
*
|
2005-12-08 |
2015-10-13 |
University Of Louisville Research Foundation, Inc. |
Uses and isolation of stem cells from bone marrow
|
PL2535403T3
(pl)
*
|
2005-12-08 |
2019-10-31 |
Univ Louisville Res Found Inc |
Bardzo małe komórki macierzyste typu embrionalnego (VSEL) oraz sposoby ich izolowania i zastosowania
|
KR20080081088A
(ko)
|
2005-12-29 |
2008-09-05 |
안트로제네시스 코포레이션 |
태반 줄기세포와 제2 세포원으로부터 얻은 줄기세포의 공동배양
|
DK2471903T3
(en)
|
2005-12-29 |
2018-05-28 |
Anthrogenesis Corp |
Placenta stem cell populations
|
CN101421393B
(zh)
*
|
2006-02-14 |
2013-08-14 |
塞勒兰特治疗公司 |
提高造血干细胞植入的方法和组合物
|
DK1993575T3
(da)
|
2006-03-07 |
2019-10-14 |
Geeta Shroff |
Sammensætninger omfattende humane embryostamceller og derivater deraf, fremgangsmåder til anvendelse og fremgangsmåder til fremstilling
|
US20100297087A1
(en)
*
|
2006-04-11 |
2010-11-25 |
Nanodiagnostics Israel., Ltd |
Pluripotent stem cells characterized by expression of germline specific genes
|
WO2007120911A2
(en)
*
|
2006-04-14 |
2007-10-25 |
Carnegie Mellon University |
Cellular labeling and quantification for nuclear magnetic resonance techniques
|
EP2012832A2
(de)
*
|
2006-04-14 |
2009-01-14 |
Celsense, Inc. |
Verfahren zur beurteilung von zellmarkierungen
|
EP2019858B1
(de)
*
|
2006-04-17 |
2012-06-13 |
BioE LLC |
Differenzierung von vorläuferzellen mit mehreren abstammungslinien in respiratorischen epithelzellen
|
US8877253B2
(en)
|
2006-05-11 |
2014-11-04 |
Regenics As |
Cellular extracts
|
US8557295B2
(en)
|
2006-05-11 |
2013-10-15 |
Regenics As |
Use of cellular extracts for skin rejuvenation
|
WO2008020329A2
(en)
|
2006-05-11 |
2008-02-21 |
Regenics As |
Administration of cells and cellular extracts for rejuvenation
|
WO2007146106A2
(en)
*
|
2006-06-05 |
2007-12-21 |
Cryo- Cell International, Inc. |
Procurement, isolation and cryopreservation of maternal placental cells
|
US20080050814A1
(en)
*
|
2006-06-05 |
2008-02-28 |
Cryo-Cell International, Inc. |
Procurement, isolation and cryopreservation of fetal placental cells
|
EP2617428A1
(de)
|
2006-08-15 |
2013-07-24 |
Agency for Science, Technology and Research |
Mit mesenchymalen Stammzellen konditioniertes Medium
|
US8785193B2
(en)
|
2006-09-14 |
2014-07-22 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Dissection tool and methods of use
|
US20120269774A1
(en)
*
|
2006-09-21 |
2012-10-25 |
Medistem Laboratories, Inc |
Allogeneic stem cell transplants in non-conditioned recipients
|
US8129184B2
(en)
|
2006-09-26 |
2012-03-06 |
Cedars-Sinai Medical Center |
Cancer stem cell antigen vaccines and methods
|
ES2441560T3
(es)
*
|
2006-11-03 |
2014-02-05 |
Aastrom Biosciences, Inc. |
Poblaciones celulares mixtas para la reparación de tejidos y técnica de separación para el procesamiento celular
|
WO2008066658A2
(en)
*
|
2006-11-03 |
2008-06-05 |
The Trustees Of Princeton University |
Engineered cellular pathways for programmed autoregulation of differentiation
|
WO2008063675A2
(en)
*
|
2006-11-24 |
2008-05-29 |
Regents Of The University Of Minnesota |
Endodermal progenitor cells
|
WO2008070861A2
(en)
*
|
2006-12-07 |
2008-06-12 |
Cellerant Therapeutics Inc. |
Methods and compositions for treating systemic lupus erythematosus
|
US20100172882A1
(en)
*
|
2007-01-11 |
2010-07-08 |
Glazer Peter M |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
EP2115460A4
(de)
|
2007-01-18 |
2010-01-13 |
Suomen Punainen Risti Veripalv |
Neues kohlenhydrat aus menschlichen zellen und verfahren zur analyse und modifikation davon
|
EP2108043A4
(de)
|
2007-01-18 |
2010-04-21 |
Suomen Punainen Risti Veripalv |
Neue verfahren und reagentien zur produktion von zellen
|
WO2008092002A2
(en)
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
AU2008216748A1
(en)
*
|
2007-02-12 |
2008-08-21 |
Anthrogenesis Corporation |
Hepatocytes and chondrocytes from adherent placental stem cells; and CD34+, CD45- placental stem cell-enriched cell populations
|
SI2120977T1
(sl)
|
2007-02-12 |
2014-01-31 |
Anthrogenesis Coroporation |
Zdravljenje vnetnih bolezni z uporabo placentarnih matičnih celic
|
WO2008106551A2
(en)
|
2007-02-28 |
2008-09-04 |
The Govt. Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health & Human Serv. |
Brachyury polypeptides and methods for use
|
US8318921B2
(en)
*
|
2007-03-01 |
2012-11-27 |
California Institute Of Technology |
Triggered RNAi
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
US20100172830A1
(en)
*
|
2007-03-29 |
2010-07-08 |
Cellx Inc. |
Extraembryonic Tissue cells and method of use thereof
|
WO2008137115A1
(en)
|
2007-05-03 |
2008-11-13 |
The Brigham And Women's Hospital, Inc. |
Multipotent stem cells and uses thereof
|
US8574567B2
(en)
*
|
2007-05-03 |
2013-11-05 |
The Brigham And Women's Hospital, Inc. |
Multipotent stem cells and uses thereof
|
JP2010525836A
(ja)
*
|
2007-05-04 |
2010-07-29 |
ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ |
ヒト造血幹細胞のexvivo増殖
|
US9217151B2
(en)
|
2007-05-16 |
2015-12-22 |
California Institute Of Technology |
Versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways
|
TWM322542U
(en)
*
|
2007-05-23 |
2007-11-21 |
Universal Scient Ind Co Ltd |
Testing machine
|
CN101835891A
(zh)
*
|
2007-06-15 |
2010-09-15 |
加内特生物治疗学股份有限公司 |
运用体外培养增殖的自我更新型集落形成细胞治疗疾病和功能紊乱症
|
AU2008275578B2
(en)
*
|
2007-07-10 |
2014-04-10 |
Carnegie Mellon University |
Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
|
CN101835479A
(zh)
*
|
2007-07-25 |
2010-09-15 |
佰欧益有限公司 |
多系祖细胞分化为软骨细胞
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
KR101645311B1
(ko)
*
|
2007-09-26 |
2016-08-03 |
안트로제네시스 코포레이션 |
인간 태반 관류액으로부터의 혈관형성 세포
|
NZ617412A
(en)
|
2007-09-28 |
2015-06-26 |
Anthrogenesis Corp |
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
|
WO2009058983A2
(en)
*
|
2007-10-30 |
2009-05-07 |
University Of Louisville Research Foundation, Inc. |
Subpopulations of bone marrow-derived adherent stem cells and methods of use therefor
|
CN101978046A
(zh)
*
|
2007-10-30 |
2011-02-16 |
路易斯维尔大学研究基金会有限公司 |
非常小的胚胎样(vsel)干细胞的应用和分离
|
CA2704746A1
(en)
*
|
2007-11-07 |
2009-05-14 |
Anthrogenesis Corporation |
Use of umbilical cord blood in the treatment of premature birth complications
|
AU2009212747B2
(en)
|
2008-01-31 |
2013-11-07 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Engineered antibody constant domain molecules
|
US8497364B2
(en)
*
|
2008-02-27 |
2013-07-30 |
California Institute Of Technology |
Triggered RNAi
|
WO2009116951A2
(en)
|
2008-03-17 |
2009-09-24 |
Agency For Science, Technology And Research |
Microcarriers for stem cell culture
|
CA2719740C
(en)
|
2008-03-28 |
2018-11-20 |
Stemcyte, Inc. |
Treatment of brain damage using umbilical cord blood cells
|
EP2280736B1
(de)
*
|
2008-05-02 |
2016-11-02 |
Celsense Inc. |
Zusammensetzungen und verfahren zur herstellung von emulsionen für kernmagnetresonanzverfahren und andere anwendungen
|
US20090291494A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Bioe, Inc. |
Differentiation of Multi-Lineage Progenitor Cells to Pancreatic Cells
|
US20100021904A1
(en)
*
|
2008-05-21 |
2010-01-28 |
Pierce Niles A |
Shielded cross-linking probes
|
US8241854B2
(en)
|
2008-05-22 |
2012-08-14 |
California Institute Of Technology |
Triggered RNAi
|
US20100021901A1
(en)
*
|
2008-05-22 |
2010-01-28 |
Peng Yin |
Compositions and methods for detecting analytes
|
US8632768B2
(en)
|
2008-05-30 |
2014-01-21 |
University Of Louisville Research Foundation, Inc. |
Human facilitating cells
|
US11291686B2
(en)
|
2008-05-30 |
2022-04-05 |
University Of Louisville Research Foundation, Inc. |
Human facilitating cells
|
EP2318832B1
(de)
|
2008-07-15 |
2013-10-09 |
Academia Sinica |
Glycan-arrays auf objektträgern mit ptfe-aluminiumbeschichtung und entsprechende verfahren
|
AU2009283216B2
(en)
|
2008-08-20 |
2015-04-02 |
Celularity Inc. |
Improved cell composition and methods of making the same
|
PE20110399A1
(es)
|
2008-08-20 |
2011-06-22 |
Anthrogenesis Corp |
Tratamiento de la apoplejia utilizando celulas placentarias aisladas
|
RU2011110736A
(ru)
|
2008-08-22 |
2012-09-27 |
Антродженезис Корпорейшн (Us) |
Способы и композиции для лечения костных дефектов с помощью плацентарных клеточных популяций
|
EP2385371B1
(de)
|
2008-09-22 |
2014-10-22 |
Oregon Health and Science University |
Verfahren zum Erkennen einer Infektion mit dem Mycobakterium tuberculosis
|
JP5792621B2
(ja)
|
2008-09-26 |
2015-10-14 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
frizzled結合剤およびその使用
|
EP2334701A4
(de)
|
2008-10-16 |
2014-01-08 |
Univ Pittsburgh |
Vollständig menschliche antikörper gegen mit melanomen von hohem molekulargewicht assoziierte antigene und verwendungen davon
|
BRPI0922184A2
(pt)
|
2008-11-19 |
2020-08-18 |
Anthrogenesis Corporation |
célula isolada, população isolada de células, matriz ou estrutura sintética permanente ou decelularizada degradável, e , método para tratar um indivíduo
|
RU2570550C2
(ru)
*
|
2008-11-21 |
2015-12-10 |
Антродженезис Корпорейшн |
Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток
|
RU2497532C2
(ru)
*
|
2008-12-03 |
2013-11-10 |
Эморсайт, Инк. |
Композиции, улучшающие перфузию в области инфаркта и способы восстановления сосудистого повреждения
|
CA2747418A1
(en)
|
2008-12-16 |
2010-07-01 |
Onconova Therapeutics, Inc. |
Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxic agents
|
US8664183B2
(en)
|
2009-02-27 |
2014-03-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
SPANX-B polypeptides and their use
|
US20100239539A1
(en)
*
|
2009-03-23 |
2010-09-23 |
Sing George L |
Methods for promoting differentiation and differentiation efficiency
|
NZ619359A
(en)
*
|
2009-07-02 |
2015-07-31 |
Anthrogenesis Corp |
Method of producing erythrocytes without feeder cells
|
JP5828838B2
(ja)
|
2009-07-15 |
2015-12-09 |
カリミューン, インコーポレーティッド |
ヒト免疫不全ウイルス阻害のための二重ベクター
|
SG178064A1
(en)
|
2009-07-21 |
2012-03-29 |
Abt Holding Co |
Use of stem cells to reduce leukocyte extravasation
|
EP2462230B1
(de)
|
2009-08-03 |
2015-07-15 |
Recombinetics, Inc. |
Verfahren und zusammensetzungen für gezielte genmodifikation
|
WO2011053989A2
(en)
|
2009-11-02 |
2011-05-05 |
Yale University |
Polymeric materials loaded with mutagenic and recombinagenic nucleic acids
|
CN102762720B
(zh)
|
2009-11-12 |
2015-03-11 |
Vbi技术有限责任公司 |
类孢子细胞子群及其用途
|
US8961989B2
(en)
|
2009-11-20 |
2015-02-24 |
Oregon Health & Science University |
Methods for producing an immune response to tuberculosis
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Wnt拮抗劑及治療和篩選方法
|
EP2529007B1
(de)
|
2010-01-26 |
2017-07-12 |
Anthrogenesis Corporation |
Behandlung von knochenbedingten karzinomen mit plazentastammzellen
|
IL282662B2
(en)
|
2010-02-25 |
2024-01-01 |
Univ Case Western Reserve |
Modulation of macrophage activation
|
NZ602700A
(en)
|
2010-04-01 |
2014-10-31 |
Oncomed Pharm Inc |
Frizzled-binding agents and uses thereof
|
KR20220015489A
(ko)
|
2010-04-07 |
2022-02-08 |
셀룰래리티 인코포레이티드 |
태반 줄기 세포를 사용한 혈관신생
|
US9746459B2
(en)
|
2010-04-08 |
2017-08-29 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Antigen presenting cell assay
|
CN102933221A
(zh)
|
2010-04-08 |
2013-02-13 |
人类起源公司 |
使用胎盘干细胞治疗结节病
|
EP3730943A1
(de)
|
2010-04-08 |
2020-10-28 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Zellenassay mit b-zellen-antigenen
|
US10338069B2
(en)
|
2010-04-12 |
2019-07-02 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
US20110293585A1
(en)
|
2010-04-21 |
2011-12-01 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
US20110262406A1
(en)
|
2010-04-21 |
2011-10-27 |
Yale University |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
JP5841322B2
(ja)
|
2010-04-22 |
2016-01-13 |
オレゴン ヘルス アンド サイエンス ユニバーシティ |
フマリルアセト酢酸ヒドロラーゼ(fah)欠損性ブタおよびその使用
|
PT2561078T
(pt)
|
2010-04-23 |
2018-12-03 |
Cold Spring Harbor Laboratory |
Sharn com uma conceção estrutural inovadora
|
US8658780B2
(en)
|
2010-05-18 |
2014-02-25 |
California Institute Of Technology |
Triggered covalent probes for imaging and silencing genetic expression
|
EP2582793B1
(de)
|
2010-06-15 |
2017-09-06 |
Cellular Dynamics International, Inc. |
Kompendium aus fertig gebauten stammzellmodellen zur abfrage biologischer reaktionen
|
US8497354B2
(en)
|
2010-06-16 |
2013-07-30 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Antibodies to endoplasmin and their use
|
WO2012006440A2
(en)
|
2010-07-07 |
2012-01-12 |
Cellular Dynamics International, Inc. |
Endothelial cell production by programming
|
BR112013000822B1
(pt)
|
2010-07-13 |
2021-02-23 |
Anthrogenesis Corporation |
Método in vitro em duas etapas para a produção de uma população decélulas exterminadoras naturais (nk) ativadas
|
US9834439B2
(en)
|
2010-07-20 |
2017-12-05 |
California Institute Of Technology |
Biomolecular self-assembly
|
US8877438B2
(en)
|
2010-07-20 |
2014-11-04 |
California Institute Of Technology |
Self-assembled polynucleotide structure
|
US8962241B2
(en)
|
2010-07-20 |
2015-02-24 |
California Institute Of Technology |
Triggered molecular geometry based bioimaging probes
|
US20140030232A1
(en)
|
2010-08-12 |
2014-01-30 |
Fate Therapeutics, Inc. |
Hematopoietic stem and progenitor cell therapy
|
WO2012048298A2
(en)
|
2010-10-08 |
2012-04-12 |
Caridianbct, Inc. |
Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
|
US8574899B2
(en)
|
2010-12-22 |
2013-11-05 |
Vladimir B Serikov |
Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
|
WO2012092323A1
(en)
|
2010-12-28 |
2012-07-05 |
Xoma Technology Ltd. |
Cell surface display using pdz domains
|
EP2658557A1
(de)
|
2010-12-31 |
2013-11-06 |
Anthrogenesis Corporation |
Verbesserung der plazentastammzellenpotenz mit modulatorischen rna-molekülen
|
EP2673358B1
(de)
|
2011-02-08 |
2019-01-09 |
FUJIFILM Cellular Dynamics, Inc. |
Herstellung blutbildender vorläuferzellen durch programmierung
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
EP3070104B1
(de)
|
2011-04-19 |
2017-12-27 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Für glypican-3 spezifische humane monoklonale antikörper und ihre verwendung
|
CN104220081A
(zh)
|
2011-06-01 |
2014-12-17 |
人类起源公司 |
利用胎盘干细胞治疗疼痛
|
KR102073530B1
(ko)
|
2011-06-06 |
2020-02-04 |
리제네시스 비브이비에이 |
중공 섬유 생물 반응기에서의 줄기 세포의 확장
|
AU2012267512B2
(en)
|
2011-06-10 |
2014-11-20 |
Bluebird Bio, Inc. |
Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
|
AU2012284365B2
(en)
|
2011-07-15 |
2017-04-20 |
The General Hospital Corporation |
Methods of transcription activator like effector assembly
|
DK2747551T3
(da)
|
2011-08-26 |
2020-05-18 |
Yecuris Corp |
Fumarylacetoacetate-hydrolase (FAH)-deficiente og immundeficiente rotter og anvendelser deraf
|
US9925221B2
(en)
|
2011-09-09 |
2018-03-27 |
Celularity, Inc. |
Treatment of amyotrophic lateral sclerosis using placental stem cells
|
KR101958612B1
(ko)
|
2011-09-23 |
2019-03-14 |
블루버드 바이오, 인코포레이티드. |
개선된 유전자 치료 방법
|
IN2014CN02518A
(de)
|
2011-09-30 |
2015-07-31 |
Bluebird Bio Inc |
|
ES2682255T3
(es)
|
2011-12-02 |
2018-09-19 |
Fate Therapeutics, Inc. |
Métodos mejorados de tratamiento de isquemia
|
JP6220791B2
(ja)
|
2011-12-02 |
2017-10-25 |
フェイト セラピューティクス,インコーポレイテッド |
増強された幹細胞組成物
|
TWI443107B
(zh)
|
2011-12-29 |
2014-07-01 |
Ind Tech Res Inst |
人源化之抗人類細胞表面抗原cd34之單株抗體及其應用
|
EP2825557B1
(de)
|
2012-03-16 |
2017-06-28 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Manipuliertes lösliches monomeres fc
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
CN104520331B
(zh)
|
2012-06-01 |
2018-09-07 |
美国政府(由卫生和人类服务部的部长所代表) |
磷脂酰肌醇蛋白聚糖3的高亲和力单克隆抗体及其用途
|
ES2869701T3
(es)
|
2012-08-01 |
2021-10-25 |
United Therapeutics Corp |
Tratamiento de hipertensión arterial pulmonar con células progenitoras endoteliales tratadas con prostaciclina
|
AU2013296611B2
(en)
|
2012-08-01 |
2017-11-23 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
|
JP6302909B2
(ja)
|
2012-08-18 |
2018-03-28 |
アカデミア シニカAcademia Sinica |
シアリダーゼの同定および画像化のための細胞透過性プローブ
|
WO2014031476A1
(en)
|
2012-08-21 |
2014-02-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin domain-specific monoclonal antibodies and use thereof
|
US9416190B2
(en)
|
2012-09-27 |
2016-08-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin antibodies and methods for eliciting potent antitumor activity
|
US9266959B2
(en)
|
2012-10-23 |
2016-02-23 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using frizzled-binding agents
|
WO2014085593A1
(en)
|
2012-11-27 |
2014-06-05 |
Children's Medical Center Corporation |
Targeting bcl11a distal regulatory elements for fetal hemoglobin reinduction
|
EP3459522B1
(de)
|
2012-12-10 |
2021-02-17 |
Regenics AS |
Verwendung von zellextrakten zur wundbehandlung
|
ES2963968T3
(es)
|
2013-01-09 |
2024-04-03 |
United Therapeutics Corp |
Tratamiento de la vasculopatía con prostaciclina y células madre mesenquimatosas
|
WO2014120714A1
(en)
|
2013-01-30 |
2014-08-07 |
Cornell University |
Compositions and methods for the expansion of stem cells
|
CA2899353A1
(en)
|
2013-02-04 |
2014-08-07 |
Oncomed Pharmaceuticals, Inc. |
Methods and monitoring of treatment with a wnt pathway inhibitor
|
CN115282165A
(zh)
|
2013-02-05 |
2022-11-04 |
细胞结构公司 |
来自胎盘的自然杀伤细胞
|
US20140242595A1
(en)
|
2013-02-22 |
2014-08-28 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
WO2014150602A1
(en)
|
2013-03-15 |
2014-09-25 |
Fate Therapeutics, Inc. |
Cell potency assay for therapeutic potential
|
US9943545B2
(en)
|
2013-03-15 |
2018-04-17 |
Fate Therapeutics, Inc. |
Stem cell culture media and methods of enhancing cell survival
|
EP2981605B1
(de)
|
2013-04-03 |
2019-06-19 |
FUJIFILM Cellular Dynamics, Inc. |
Verfahren und zusammensetzungen zur kultivierung von endoderm-vorläuferzellen in einer suspension
|
ES2827250T3
(es)
|
2013-04-12 |
2021-05-20 |
Houston Methodist Hospital |
Mejora de órganos para trasplante
|
WO2014184666A2
(en)
|
2013-04-30 |
2014-11-20 |
Katholieke Universiteit Leuven |
Cell therapy for myelodysplastic syndromes
|
US9758763B2
(en)
|
2013-05-29 |
2017-09-12 |
The Regents Of The University Of California |
Methods and compositions for somatic cell proliferation and viability
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
WO2014210564A1
(en)
|
2013-06-27 |
2014-12-31 |
Academia Sinica |
Glycan conjugates and use thereof
|
US9856472B2
(en)
|
2013-07-01 |
2018-01-02 |
California Institute Of Technology |
Small conditional RNAs
|
KR102298172B1
(ko)
|
2013-09-06 |
2021-09-06 |
아카데미아 시니카 |
변화된 글리코실 그룹을 갖는 당지질을 사용한 인간 iNKT 세포 활성화
|
JP6517197B2
(ja)
|
2013-10-15 |
2019-05-22 |
ケース ウエスタン リザーブ ユニバーシティ |
短鎖デヒドロゲナーゼ活性を調節する組成物および方法
|
US9617506B2
(en)
|
2013-11-16 |
2017-04-11 |
Terumo Bct, Inc. |
Expanding cells in a bioreactor
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
WO2016114819A1
(en)
|
2015-01-16 |
2016-07-21 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
WO2015109180A2
(en)
|
2014-01-16 |
2015-07-23 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US11008547B2
(en)
|
2014-03-25 |
2021-05-18 |
Terumo Bct, Inc. |
Passive replacement of media
|
CN106415244B
(zh)
|
2014-03-27 |
2020-04-24 |
中央研究院 |
反应性标记化合物及其用途
|
WO2015164228A1
(en)
|
2014-04-21 |
2015-10-29 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
JP6514717B2
(ja)
|
2014-04-25 |
2019-05-15 |
ザ チルドレンズ メディカル センター コーポレーション |
異常ヘモグロビン症を治療するための組成物および方法
|
WO2015172149A1
(en)
|
2014-05-09 |
2015-11-12 |
Yale University |
Hyperbranched polyglycerol-coated particles and methods of making and using thereof
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
EP3149036A4
(de)
|
2014-05-27 |
2017-12-27 |
Academia Sinica |
Anti-cd20-glycoantikörper und verwendungen davon
|
KR102512592B1
(ko)
|
2014-05-27 |
2023-03-21 |
아카데미아 시니카 |
항-her2 글리코항체 및 이의 용도
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
EP3149045B1
(de)
|
2014-05-27 |
2023-01-18 |
Academia Sinica |
Zusammensetzungen und verfahren im zusammenhang mit universellen glykoformen für erhöhte antikörpereffizienz
|
CA2950433A1
(en)
|
2014-05-28 |
2015-12-03 |
Academia Sinica |
Anti-tnf-alpha glycoantibodies and uses thereof
|
US11278572B2
(en)
|
2014-07-18 |
2022-03-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Reducing CXCR4 expression and/or function to enhance engraftment of hematopoietic stem cells
|
EP3473271B1
(de)
|
2014-07-31 |
2022-07-20 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Humane monoklonale antikörper gegen epha4 und deren verwendung
|
US9879042B2
(en)
|
2014-09-08 |
2018-01-30 |
Academia Sinica |
Human iNKT cell activation using glycolipids
|
WO2016040895A1
(en)
|
2014-09-12 |
2016-03-17 |
xxTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
Wnt signaling agonist molecules
|
JP6830059B2
(ja)
|
2014-09-26 |
2021-02-17 |
テルモ ビーシーティー、インコーポレーテッド |
スケジュール化された細胞フィーディング
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10342858B2
(en)
|
2015-01-24 |
2019-07-09 |
Academia Sinica |
Glycan conjugates and methods of use thereof
|
EP3770252A1
(de)
|
2015-01-26 |
2021-01-27 |
Fate Therapeutics, Inc. |
Zellen mit erhöhten immunregulatorischen eigenschaften und verfahren zu deren verwendung und herstellung
|
ES2835861T3
(es)
|
2015-05-08 |
2021-06-23 |
Childrens Medical Ct Corp |
Direccionamiento de regiones funcionales del potenciador de BCL11A para la reinducción de hemoglobina fetal
|
AU2016263808B2
(en)
|
2015-05-21 |
2019-01-03 |
Harpoon Therapeutics, Inc. |
Trispecific binding proteins and methods of use
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
RU2757818C2
(ru)
|
2015-07-20 |
2021-10-21 |
Анджиокрин Биосайенс, Инк. |
Способы и композиции для трансплантации стволовых клеток
|
KR20180033537A
(ko)
|
2015-07-21 |
2018-04-03 |
더 칠드런스 메디칼 센터 코포레이션 |
Pd-l1 발현 조혈 줄기 세포 및 용도
|
US11312940B2
(en)
|
2015-08-31 |
2022-04-26 |
University Of Louisville Research Foundation, Inc. |
Progenitor cells and methods for preparing and using the same
|
KR20180050339A
(ko)
|
2015-09-04 |
2018-05-14 |
오비아이 파머 인코퍼레이티드 |
글리칸 어레이 및 사용 방법
|
WO2017066561A2
(en)
|
2015-10-16 |
2017-04-20 |
President And Fellows Of Harvard College |
Regulatory t cell pd-1 modulation for regulating t cell effector immune responses
|
KR20180110112A
(ko)
|
2016-02-12 |
2018-10-08 |
블루버드 바이오, 인코포레이티드. |
Vcn 인핸서 조성물 및 이의 사용 방법
|
CN108883136A
(zh)
|
2016-02-12 |
2018-11-23 |
蓝鸟生物公司 |
Vcn增强子组合物及其使用方法
|
CA3014795A1
(en)
|
2016-02-16 |
2017-08-24 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
AU2017221405A1
(en)
|
2016-02-16 |
2018-09-20 |
Carnegie Mellon University |
Compositions for enhancing targeted gene editing and methods of use thereof
|
WO2017147212A1
(en)
|
2016-02-22 |
2017-08-31 |
The Regents Of The University Of California |
Compositions and methods for imaging cell populations
|
WO2017152073A1
(en)
|
2016-03-04 |
2017-09-08 |
University Of Louisville Research Foundation, Inc. |
Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (vsels)
|
CA3016170A1
(en)
|
2016-03-08 |
2017-09-14 |
Academia Sinica |
Methods for modular synthesis of n-glycans and arrays thereof
|
KR20190080825A
(ko)
|
2016-03-21 |
2019-07-08 |
다나-파버 캔서 인스티튜트 인크. |
T-세포 기능소실 상태-특이적 유전자 발현 조절인자 및 그 용도
|
JP2019513144A
(ja)
|
2016-03-29 |
2019-05-23 |
オービーアイ ファーマ,インコーポレイテッド |
抗体、医薬組成物及び方法
|
US10980894B2
(en)
|
2016-03-29 |
2021-04-20 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
EP3436035A4
(de)
|
2016-03-29 |
2019-10-23 |
SmsBiotech, Inc. |
Zusammensetzungen und verfahren zur verwendung kleiner mobiler stammzellen
|
KR20230110820A
(ko)
|
2016-04-22 |
2023-07-25 |
오비아이 파머 인코퍼레이티드 |
글로보 계열 항원을 통한 면역 활성화 또는 면역 조정에의한 암 면역요법
|
WO2017196847A1
(en)
|
2016-05-10 |
2017-11-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Variable new antigen receptor (vnar) antibodies and antibody conjugates targeting tumor and viral antigens
|
MX2018014227A
(es)
|
2016-05-20 |
2019-08-22 |
Harpoon Therapeutics Inc |
Proteinas de union de cadena unica de fragmento variable cd3.
|
US11623958B2
(en)
|
2016-05-20 |
2023-04-11 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment CD3 binding proteins
|
WO2017201488A1
(en)
|
2016-05-20 |
2017-11-23 |
Harpoon Therapeutics, Inc. |
Single domain serum albumin binding protein
|
US11965175B2
(en)
|
2016-05-25 |
2024-04-23 |
Terumo Bct, Inc. |
Cell expansion
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
WO2017214182A1
(en)
|
2016-06-07 |
2017-12-14 |
The United States Of America. As Represented By The Secretary, Department Of Health & Human Services |
Fully human antibody targeting pdi for cancer immunotherapy
|
IL302802A
(en)
|
2016-07-05 |
2023-07-01 |
California Inst Of Techn |
Hybridization chain reaction based on a minimal initiator
|
KR20190067765A
(ko)
|
2016-07-27 |
2019-06-17 |
오비아이 파머 인코퍼레이티드 |
면역원성/치료 글리칸 조성물 및 그의 용도
|
KR102528998B1
(ko)
|
2016-07-29 |
2023-05-03 |
오비아이 파머 인코퍼레이티드 |
인간 항체, 제약 조성물 및 방법
|
EP3494135A1
(de)
|
2016-08-02 |
2019-06-12 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Gegen glypican-2 (gpc2) gerichtete monoklonale antikörper und verwendung davon
|
CN109963868B
(zh)
|
2016-08-22 |
2023-11-14 |
醣基生医股份有限公司 |
抗体、结合片段及使用方法
|
CA3034617A1
(en)
|
2016-08-30 |
2018-03-08 |
California Institute Of Technology |
Immunohistochemistry via hybridization chain reaction
|
US11571444B2
(en)
|
2016-10-24 |
2023-02-07 |
United Therapeutics Corporation |
Enhancement of MSC immunomodulatory properties by treprostinil
|
CA3044274A1
(en)
|
2016-11-21 |
2018-05-24 |
Obi Pharma, Inc. |
Conjugated biological molecules, pharmaceutical compositions and methods
|
WO2018098354A1
(en)
|
2016-11-23 |
2018-05-31 |
Harpoon Therapeutics, Inc. |
Prostate specific membrane antigen binding protein
|
EP3544629A4
(de)
|
2016-11-23 |
2020-06-17 |
Harpoon Therapeutics, Inc. |
Auf trispezifische proteine abzielende psma und verfahren zur verwendung
|
WO2018102552A1
(en)
|
2016-11-30 |
2018-06-07 |
Case Western Reserve University |
Combinations of 15-pgdh inhibitors with corcosteroids and/or tnf inhibitors and uses thereof
|
CA3045902A1
(en)
|
2016-12-21 |
2018-06-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies specific for flt3 and uses thereof
|
AU2018215678A1
(en)
|
2017-02-06 |
2019-08-22 |
Board Of Regents Of The University Of Texas System |
Compositions and methods of modulating short-chain dehydrogenase activity
|
EP3583203B1
(de)
|
2017-02-15 |
2023-11-01 |
2seventy bio, Inc. |
Spenderreparaturtemplates für multiplex-genomeditierung
|
WO2018160754A2
(en)
|
2017-02-28 |
2018-09-07 |
Harpoon Therapeutics, Inc. |
Inducible monovalent antigen binding protein
|
US11261441B2
(en)
|
2017-03-29 |
2022-03-01 |
Bluebird Bio, Inc. |
Vectors and compositions for treating hemoglobinopathies
|
CN117247899A
(zh)
|
2017-03-31 |
2023-12-19 |
泰尔茂比司特公司 |
细胞扩增
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
US20200113821A1
(en)
|
2017-04-04 |
2020-04-16 |
Yale University |
Compositions and methods for in utero delivery
|
AU2018261637A1
(en)
|
2017-05-03 |
2019-12-12 |
Biomarin Pharmaceutical Inc. |
Improved lentiviruses for transduction of hematopoietic stem cells.
|
US10730954B2
(en)
|
2017-05-12 |
2020-08-04 |
Harpoon Therapeutics, Inc. |
MSLN targeting trispecific proteins and methods of use
|
BR112019023855B1
(pt)
|
2017-05-12 |
2021-11-30 |
Harpoon Therapeutics, Inc |
Proteínas de ligação à mesotelina
|
AU2018268970A1
(en)
|
2017-05-19 |
2019-10-24 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibody targeting tnfr2 for cancer immunotherapy
|
US11788087B2
(en)
|
2017-05-25 |
2023-10-17 |
The Children's Medical Center Corporation |
BCL11A guide delivery
|
CA3061959A1
(en)
|
2017-06-09 |
2018-12-13 |
Providence Health & Services - Oregon |
Utilization of cd39 and cd103 for identification of human tumor reactive t cells for treatment of cancer
|
WO2019005208A1
(en)
|
2017-06-30 |
2019-01-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
ANTIBODIES TO HUMAN MESOTHELIN AND USES IN ANTICANCER THERAPY
|
WO2019006280A1
(en)
|
2017-06-30 |
2019-01-03 |
Lentigen Technology, Inc. |
HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO CD33 AND METHODS OF USE
|
WO2019060708A1
(en)
|
2017-09-22 |
2019-03-28 |
The Children's Medical Center Corporation |
TREATMENT OF TYPE 1 DIABETES AND AUTOIMMUNE DISEASES OR DISORDERS
|
SG11202003341UA
(en)
|
2017-10-13 |
2020-05-28 |
Harpoon Therapeutics Inc |
B cell maturation antigen binding proteins
|
EP3694529B1
(de)
|
2017-10-13 |
2024-06-26 |
Harpoon Therapeutics, Inc. |
Trispezifische proteine und verfahren zur verwendung
|
US10821155B2
(en)
|
2018-06-27 |
2020-11-03 |
Juvena Therapeutics, Inc. |
Heparin-associated polypeptides and uses thereof
|
TW202035444A
(zh)
|
2018-06-27 |
2020-10-01 |
台灣浩鼎生技股份有限公司 |
用於糖蛋白工程的糖苷合成酶變體及其使用方法
|
US11939377B2
(en)
|
2018-07-12 |
2024-03-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Affinity matured CD22-specific monoclonal antibody and uses thereof
|
EP3833684A1
(de)
|
2018-08-08 |
2021-06-16 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Gegen glypican-2 gerichtete, hochaffine monoklonale antikörper und verwendungen davon
|
US20210338815A1
(en)
|
2018-08-31 |
2021-11-04 |
Yale University |
Compositions and methods for enhancing triplex and nuclease-based gene editing
|
US20210340280A1
(en)
|
2018-08-31 |
2021-11-04 |
Yale University |
Compositions and methods for enhancing donor oligonucleotide-based gene editing
|
JP7425049B2
(ja)
|
2018-09-25 |
2024-01-30 |
ハープーン セラピューティクス,インク. |
Dll3結合タンパク質および使用方法
|
WO2020072618A1
(en)
|
2018-10-02 |
2020-04-09 |
Immunome, Inc. |
Antibodies targeting epn1
|
WO2020082076A1
(en)
|
2018-10-19 |
2020-04-23 |
Board Of Regents, The University Of Texas System |
Engineered long interspersed element (line) transposons and methods of use thereof
|
WO2020106998A1
(en)
|
2018-11-21 |
2020-05-28 |
Case Western Reserve University |
Compositions and methods of modulating short-chain dehydrogenase activity
|
WO2020113025A1
(en)
|
2018-11-28 |
2020-06-04 |
Milica Radisic |
Methods for tissue generation
|
WO2020112195A1
(en)
|
2018-11-30 |
2020-06-04 |
Yale University |
Compositions, technologies and methods of using plerixafor to enhance gene editing
|
AU2020206308A1
(en)
|
2019-01-08 |
2021-07-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cross-species single domain antibodies targeting mesothelin for treating solid tumors
|
CA3125033A1
(en)
|
2019-01-22 |
2020-07-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
High affinity monoclonal antibodies targeting glypican-1 and methods of use
|
US20220267462A1
(en)
|
2019-05-14 |
2022-08-25 |
Harpoon Therapeutics, Inc. |
Epcam binding proteins and methods of use
|
US20210008161A1
(en)
|
2019-06-17 |
2021-01-14 |
Crispr Therapeutics Ag |
Methods and compositions for improved homology directed repair
|
US20220372474A1
(en)
|
2019-06-21 |
2022-11-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
WO2020257776A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
WO2021022161A1
(en)
|
2019-07-31 |
2021-02-04 |
Yale University |
Compositions and methods for treating sickle cell disease
|
AU2020336992A1
(en)
|
2019-08-30 |
2022-04-14 |
Yale University |
Compositions and methods for delivery of nucleic acids to cells
|
WO2021081052A1
(en)
|
2019-10-22 |
2021-04-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
High affinity nanobodies targeting b7h3 (cd276) for treating multiple solid tumors
|
CA3170833A1
(en)
|
2020-02-21 |
2021-08-26 |
Harpoon Therapeutics, Inc. |
Flt3 binding proteins and methods of use
|
CA3183262A1
(en)
|
2020-05-20 |
2021-11-25 |
Rodeo Therapeutics Corporation |
Compositions and methods of modulating short-chain dehydrogenase activity
|
CN116529266A
(zh)
|
2020-08-31 |
2023-08-01 |
耶鲁大学 |
用于将核酸递送到细胞的组合物和方法
|
US20230391852A1
(en)
|
2020-10-26 |
2023-12-07 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting sars coronavirus spike protein and uses thereof
|
AU2021400745A1
(en)
|
2020-12-17 |
2023-07-20 |
Vertex Pharmaceuticals Incorporated |
Compositions and methods for editing beta-globin for treatment of hemaglobinopathies
|
EP4284925A1
(de)
|
2021-01-26 |
2023-12-06 |
California Institute of Technology |
Allosterische bedingte guide-rnas zur zellselektiven regulierung von crispr/cas
|
WO2022216942A1
(en)
|
2021-04-07 |
2022-10-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for the treatment of cancer
|
US20240218055A1
(en)
|
2021-04-29 |
2024-07-04 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Lassa virus-specific nanobodies and methods of their use
|
AU2022288058A1
(en)
|
2021-06-07 |
2023-11-16 |
Agonox, Inc. |
Cxcr5, pd-1, and icos expressing tumor reactive cd4 t cells and their use
|
WO2022261115A1
(en)
|
2021-06-07 |
2022-12-15 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
CN117500831A
(zh)
|
2021-06-09 |
2024-02-02 |
美国政府(由卫生和人类服务部的部长所代表) |
用于治疗实体瘤的靶向pd-l1的跨物种单结构域抗体
|
AU2022345251A1
(en)
|
2021-09-17 |
2024-03-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic humanized llama nanobody library and use thereof to identify sars-cov-2 neutralizing antibodies
|
WO2023076881A1
(en)
|
2021-10-26 |
2023-05-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting the s2 subunit of sars-cov-2 spike protein
|
WO2023086969A2
(en)
|
2021-11-12 |
2023-05-19 |
Ichor Medical Systems Inc. |
Treatment methods
|
WO2024020597A1
(en)
|
2022-07-22 |
2024-01-25 |
The Johns Hopkins University |
Dendrimer-enabled targeted intracellular crispr/cas system delivery and gene editing
|
WO2024050399A1
(en)
|
2022-09-01 |
2024-03-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting hpv e6/e7 oncogenic peptide/mhc complexes
|
WO2024081736A2
(en)
|
2022-10-11 |
2024-04-18 |
Yale University |
Compositions and methods of using cell-penetrating antibodies
|
WO2024119101A1
(en)
|
2022-12-01 |
2024-06-06 |
Yale University |
Stimuli-responsive traceless engineering platform for intracellular payload delivery
|